PE firm buys Rütgers units

Sincmlair, Neil
June 2005
Chemical Market Reporter;6/20/2005, Vol. 267 Issue 25, p6
Trade Publication
Reports that International Chemical Investors has acquired five fine and specialty chemicals business from Rütgers AG in Germany. Intention of the businesses to form the nucleus of a larger organization focused on mid-sized chemicals businesses with leading positions in niche markets; Involvement of WeylChem GmbH and WeylChem Corp. in custom manufacturing and pharmaceuticals; Retention of the Rütgers Organics Corp. for the wood preservatives and fire retardants business.


Related Articles

  • Albemarle to sell Thann to ICIG. Boswell, Clay // Chemical Market Reporter;8/14/2006, Vol. 270 Issue 5, p5 

    The article reports the agreement made between Albemarle Corp. and International Chemical Investors Group (ICIG) regarding the transfer of Albemarle's facility in Thann, France. Based from the agreement, ICIG will get 100% of the stock of Albemarle France SAS and its subordinate Albemarle PPC...

  • WeylChem expands with Clariant acquisition. Boswell, Clay; Chang, Joseph // ICIS Chemical Business Americas;5/14/2007, Vol. 271 Issue 19, p4 

    The article reports on the acquisition of Clariant's custom manufacturing business by International Chemical Investors Group (ICIG), a Muttenz, Switzerland-based private equity firm. The business manufactures intermediates and active ingredients for the agrochemical, pharmaceutical and polymer...

  • 5-MINUTE NEWS WATCH. Chang, Joseph // ICIS Chemical Business Americas;10/23/2006, Vol. 270 Issue 15, p8 

    The article offers news briefs from the chemical industry. Two of the active pharmaceutical ingredients and advanced intermediates facilities of Cambrex will be sold to International Chemical Investors. Ashland Distribution has been selected as the exclusive distribution agent for the line of...

  • WeylChem Hunts for 'Sizable' Deals to Further Increase Sales. Scott, Alex // Chemical Week;2/11/2008, Vol. 170 Issue 5, p21 

    The article reports that WeylChem, a private equity-owned chemicals manufacturer, is seeking major acquisitions as part of a strategy to maintain strong double-digit sales growth. The company's sales grew 70% in each of the past two years largely through acquisitions, to reach about €600...

  • ICIG builds from Cambrex. Mirasol, Feliza // ICIS Chemical Business Americas;11/6/2006, Vol. 270 Issue 17, p36 

    The article announces that International Chemical Investors Group has bought two Cambrex facilities in Europe. This acquisition is seen to improve ICIG's manufacturing capabilities because of additional GMP capacity and GMP sites. Cambrex has decided to streamline its business by focusing more...

  • Tessenderlo divests assets in Italy to ICIG. Ramesh, Deepti // Chemical Week;5/27/2013, Vol. 175 Issue 15, p16 

    The article reports that the chemical industry firm Tessenderlo Group announced it has sold its Italian subsidiary Tessenderlo Partecipazioni to International Chemical Investors Group.

  • ICIG Completes the Acquisition of VYNOVA Group.  // Chemical Engineering World;Aug2015, Vol. 50 Issue 8, p12 

    The article reports the completion by the International Chemical Investors Group (ICIG) as of August 2015 of its acquisition of polyvinyl chloride (PVC) maker Inovyn's subsidiary Vynova Group, which manufactures chlorvinyls.

  • Clariant to Sell Remaining Fine Chemicals Business to ICIG. Alperowicz, Natasha // Chemical Week;5/16/2007, Vol. 169 Issue 17, p13 

    This article reports that Clariant has agreed to sell its remaining custom manufacturing business to International Chemical Investors Group, for an undisclosed sum. The business produces non-cGMP fine chemicals for the agricultural chemicals, pharmaceutical, and polymer industries. It had sales...

  • World Briefs.  // Pharmaceutical Technology;Mar2009, Vol. 33 Issue 3, p22 

    The article offers world news briefs related to pharmaceutical industry. The International Chemical Investors Group has purchased 100% shares of Miteni from Mitsubishi and other shareholders. AstraZeneca announced a downsizing of 6,000 positions by 2013. As part of Ablynx's partnership with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics